<DOC>
	<DOCNO>NCT02377479</DOCNO>
	<brief_summary>The goal study measure serial hormonal level patient undergo clomiphene , letrozole , combination clomiphene letrozole cycle . This information may help u optimize less expensive medication ovulation induction , reduce number treatment cycle achieve successful pregnancy , use medication regimen may result few multiple gestation pregnancy .</brief_summary>
	<brief_title>Endocrinology Profile Patients Undergoing Clomiphene , Letrozole , Combination Clomiphene Letrozole Cycles</brief_title>
	<detailed_description>After initial physician consultation investigation complete , treatment option review patient . If patient chooses ovulation induction oral medication , offer participation study . If chooses participate , patient undergo ovulation induction either clomiphene , letrozole , combination medication . The patient randomize order medication regimen start . Prior start treatment cycle , serum beta-hCG ( serum beta-hCG &lt; 5IU/L ) urine pregnancy test perform rule pregnancy . During one treatment cycle , patient take 100mg clomiphene orally cycle day 3-7 . This dose routinely used ovulation induction investigator clinic . Blood work include estradiol ( E2 ) , FSH , inhibin B LH obtain cycle day 3 , 7 , 9 . As lab test routinely perform investigator REI laboratory , additional cost patient . A baseline follicle count ultrasound treatment cycle measure cycle day 3 , cycle day 12 , 13 , 14 , depend cycle length lead follicle 18mm great . Once least one follicle reach mature size , Ovidrel trigger ( 250 mcg hCG subcutaneously ) administer initiate ovulation . The patient intrauterine insemination ( IUI ) 36 hour Ovidrel injection . These procedure current standard care investigator fertility center patient unexplained infertility . Ovulation treatment cycle also confirm serum progesterone measurement &gt; 3 nmol/L cycle day 20-25 . This blood test always perform , common way assess ovulation . If patient ovulate , pregnancy test perform approximately 2 week later . If pregnancy occur , next medication would attempt patient period . During second treatment cycle , patient take 5mg Letrozole orally cycle day 3-7 . The remainder prior protocol clomiphene cycle would perform . This medication dose protocol also current standard care investigator fertility center . During third treatment cycle , patient take dose 5mg Letrozole every night 100mg clomiphene every day lunch cycle day 3-7 . The remainder prior protocol clomiphene cycle would perform . This combination dose would experimental portion protocol , do , currently standard care investigator fertility center . If patient ovulate despite give hCG subcutaneously lead follicle never reach &gt; /= 18mm , treatment cycle abandon . After patient next period , start immediately next treatment cycle . If , upon fail ovulate medication regimen , subject decline continue next medication would prefer go straight gonadotropin treatment without IVF treatment , subject still remain part study US bloodwork value obtain still involve study include . A subject complete study one cycle clomiphene , one cycle letrozole , one cycle combination clomiphene/IUI achieve . For patient achieve pregnancy end study , option undergo fertility treatment discuss primary fertility specialist .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<criteria>Age 1840 year old Body mass index ( BMI ) &gt; 18 kg/m^2 &lt; 40kg/m^2 No contraindication clomiphene letrozole Ovulatory woman 1 month without fertility medication Patients unable consent study Patients polycystic ovarian syndrome anovulatory woman</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>